This inventor holds 1 USPTO granted patent. Top assignee: Innogenetics N.v.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Marleen Vanden Haesevelde: Innovator in HIV Research
Introduction
Marleen Vanden Haesevelde is a notable inventor based in Oudenaarde, Belgium. She has made significant contributions to the field of medical research, particularly in the area of HIV diagnostics. Her work has implications for improving the detection and treatment of HIV-1 group O infections.
Latest Patents
Marleen holds a patent for "HIV-1 group O antigens and uses thereof." This invention relates to an HIV-1 group O envelope antigen comprising SEQ ID NO: 100. The patent claims the use of this antigen as a reagent in the diagnosis of HIV-1 group O infection, along with a kit designed for this purpose. She has 1 patent to her name.
Career Highlights
Marleen is associated with Innogenetics N.V., a company known for its innovative approaches in the field of biotechnology. Her work at Innogenetics has allowed her to focus on developing diagnostic tools that can enhance patient care and treatment outcomes.
Collaborations
Throughout her career, Marleen has collaborated with esteemed colleagues such as Eric DeLaporte and Martine Peeters. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Marleen Vanden Haesevelde is a pioneering inventor whose work in HIV research is making a difference in the medical field. Her contributions are vital for advancing diagnostic methods and improving healthcare outcomes for patients with HIV-1 group O infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile